Parvaneh Saffarian

Parvaneh Saffarian

Auto-generated profile, based on publicly available information

Parvaneh Saffarian

Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Tumor Biology
Verified
Journal Article
Open access
HAHossein Allahyari
Hossein Allahyari
SHSahar Heidari
Sahar Heidari
MGMehdi Ghamgosha
Mehdi Ghamgosha
PSParvaneh Saffarian
Parvaneh Saffarian
JAJafar Amani
Jafar Amani
Cancer is one of the main reasons of death in the most countries and in Iran. Immunotherapy quickly became one of the best methods of cancer treatment, along with chemotherapy and radiation. “Immunotoxin Therapy” is a promising way of cancer therapy that is mentioned in this field. Immunotoxins are made from a toxin attaching to an antibody target proteins present on cancer cells. The first-generation immunotoxins were made of a full-length toxin attached to whole monoclonal antibodies. But, these immunotoxins could bind to normal cells. DAB389IL2 was the first immunotoxin approved by the Food and Drug Administration. Current trends and researches are ongoing on finding proteins that in combination with immunotoxins have minimal immunogenicity and the most potency for target cell killing.

14 March 2014 in Journal of Food Safety
Verified
Journal Article
Closed access
PDF file
AIAbbas Ali Imanifooladi
Abbas Ali Imanifooladi
MFMaryam Chavoshi Forooshai
Maryam Chavoshi Forooshai
PSParvaneh Saffarian
Parvaneh Saffarian
RMRezvan Mehrab
Rezvan Mehrab

28 December 2015 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
PSParvaneh Saffarian
Parvaneh Saffarian
SPShahin Najar Peerayeh
Shahin Najar Peerayeh
JAJafar Amani
Jafar Amani
FEFirooz Ebrahimi
Firooz Ebrahimi
HSHamid Sedighianrad
Hamid Sedighianrad
AIAbbas Ali Imanifooladi
Abbas Ali Imanifooladi

30 August 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SMShahab Sharifi Malvajerdi
Shahab Sharifi Malvajerdi
SAShahrzad Aboutorabi
Shahrzad Aboutorabi
ASAzita Shahnazi
Azita Shahnazi
SGSaeb Gholamhosseini
Saeb Gholamhosseini
RGReza Taheri Ghahrizjani
Reza Taheri Ghahrizjani
GMGhanaatshoar Majid
Ghanaatshoar Majid

1 March 2014
Verified
Journal Article
Open access
ANAtiyeh Naderi
Atiyeh Naderi
RKRoha Kasra-Kermanshahi
Roha Kasra-Kermanshahi
SGSara Gharavi
Sara Gharavi
AIAbbas Ali Imanifooladi
Abbas Ali Imanifooladi
MAMeghdad Abdollahpour-Alitappeh
Meghdad Abdollahpour-Alitappeh
PSParvaneh Saffarian
Parvaneh Saffarian
Urinary tract infection (UTI) caused by bacteria is one of the most frequent infections in human population. Inappropriate use of antibiotics, often leads to appearance of drug resistance in bacteria. However, use of probiotic bacteria has been suggested as a partial replacement. This study was aimed to assess the antagonistic effects of Lactobacillus standard strains against bacteria isolated from UTI infections. Among 600 samples; those with ≥10,000 cfu/ml were selected as UTI positive samples. Enterococcus sp., Klebsiella pneumoniae, Enterobacter sp., and Escherichia coli were found the most prevalent UTI causative agents. All isolates were screened for multi drug resistance and subjected to the antimicrobial effects of three Lactobacillus strains by using microplate technique and the MICs amounts were determined. In order to verify the origin of antibiotic resistance of isolates, plasmid curing using ethidium bromide and acridine orange was carried out. No antagonistic activity in Lactobacilli suspension was detected against test on Enterococcus and Enterobacter strains and K. pneumoniae, which were resistant to most antibiotics. However, an inhibitory effect was observed for E. coli which were resistant to 8-9 antibiotics. In addition, L. casei was determined to be the most effective probiotic. RESULTS from replica plating suggested one of the plasmids could be related to the gene responsible for ampicillin resistance. Treatment of E. coli with probiotic suspension was not effective on inhibition of the plasmid carrying hypothetical ampicillin resistant gene. Moreover, the plasmid profiles obtained from probiotic-treated isolates were identical to untreated isolates.